SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

SPALLUTO, Giampiero
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.937
AS - Asia 1.586
EU - Europa 834
SA - Sud America 213
AF - Africa 17
OC - Oceania 1
Totale 5.588
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.877
SG - Singapore 571
CN - Cina 550
DE - Germania 182
UA - Ucraina 182
BR - Brasile 179
TR - Turchia 151
HK - Hong Kong 150
GB - Regno Unito 123
SE - Svezia 76
FI - Finlandia 68
VN - Vietnam 61
IT - Italia 49
RU - Federazione Russa 36
FR - Francia 30
MX - Messico 29
CA - Canada 28
IN - India 27
JP - Giappone 22
PL - Polonia 22
ES - Italia 17
AR - Argentina 14
AT - Austria 14
ZA - Sudafrica 14
BD - Bangladesh 12
NL - Olanda 9
LT - Lituania 8
BE - Belgio 6
EC - Ecuador 6
JO - Giordania 6
ID - Indonesia 5
CZ - Repubblica Ceca 4
PY - Paraguay 4
TW - Taiwan 4
IR - Iran 3
PK - Pakistan 3
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
CL - Cile 2
CO - Colombia 2
IQ - Iraq 2
KZ - Kazakistan 2
MA - Marocco 2
MY - Malesia 2
PE - Perù 2
PS - Palestinian Territory 2
RS - Serbia 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
AL - Albania 1
BG - Bulgaria 1
BY - Bielorussia 1
DM - Dominica 1
EG - Egitto 1
GY - Guiana 1
IE - Irlanda 1
IL - Israele 1
JM - Giamaica 1
KG - Kirghizistan 1
KR - Corea 1
LV - Lettonia 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PT - Portogallo 1
QA - Qatar 1
SY - Repubblica araba siriana 1
VE - Venezuela 1
Totale 5.588
Salva come PNG Salva come JPEG
Città #
Singapore 345
Woodbridge 272
Chandler 251
Ashburn 250
Houston 226
Fairfield 204
Jacksonville 198
Beijing 184
Ann Arbor 164
Hong Kong 150
Santa Clara 134
Nanjing 87
Wilmington 85
Izmir 75
Dallas 72
Seattle 66
Cambridge 53
Munich 49
Los Angeles 46
Princeton 46
Boardman 35
Dearborn 35
New York 35
Shanghai 25
Shenyang 22
São Paulo 21
Turku 21
Ho Chi Minh City 19
Nanchang 19
London 18
Hefei 17
San Diego 17
Brooklyn 16
Mexico City 16
Milan 16
Tianjin 16
Tokyo 15
Addison 14
Falkenstein 14
Frankfurt am Main 14
San Mateo 14
Vienna 14
Warsaw 14
Changsha 13
Buffalo 11
Hanoi 11
Jiaxing 11
San Francisco 11
Chennai 10
Hebei 10
Orem 10
Atlanta 9
Helsinki 9
Jinan 9
Moscow 9
Toronto 9
Bremen 8
Chicago 8
Falls Church 8
Johannesburg 8
Kunming 8
Norwalk 8
Poplar 8
Zhengzhou 8
Boston 7
Ningbo 7
Ottawa 7
Phoenix 7
Taizhou 7
Amman 6
Brussels 6
Philadelphia 6
Rio de Janeiro 6
Denver 5
Ferrara 5
Manchester 5
Montreal 5
Mumbai 5
Verona 5
Ankara 4
Olomouc 4
Queens 4
Stockholm 4
Tampa 4
The Dalles 4
Augusta 3
Belo Horizonte 3
Bexley 3
Biên Hòa 3
Charlotte 3
Council Bluffs 3
Da Nang 3
Des Moines 3
Düsseldorf 3
Guangzhou 3
Haikou 3
Itanhaém 3
Itaquaquecetuba 3
Lanzhou 3
Louisville 3
Totale 3.758
Salva come PNG Salva come JPEG
Nome #
4-Isopropyl-2-oxazolin-5-one anion as a new convenient formyl anion equivalent for conjugate addition and aldol reactions 285
A formal total synthesis (±)-forskolin through [3+2] nitrile oxide cycloaddition chemistry 233
4-Isopropyl-2-oxazolin-5-one anion as masked umpoled synthon for both formyl and hydroxycarbonyl anions: generation, reactivity and synthetic applications 213
Enantioselective synthesis of (-)-meroquinene through tandem Michael reaction methodology 208
Changes in cortical ACh and GABA outflow during morphine withdrawal involve alpha-1 and alpha-2 receptors 207
5‐Hydroxytryptamine‐mediated effects of nicotine on endogenous GABA efflux from guinea‐pig cortical slices 201
Mastering β-Keto Esters 192
Synthesis, in vitro antiproliferative activity, and DNA-binding properties of hybrid molecules containing pyrrolo[2,1-c][1,4] benzodiazepine and minor-groove-binding oligopyrrole carriers 190
A new synthetic approach to indazole synthesis 182
[H-3]MRE 3008F20: A novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors 181
7-substituted-5-amino-2-(furyl)-pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: importance of modifications at the side chain on the activity and solubility. 177
Alpha-2 adrenoreceptor-mediated decrease in gamma-aminobutyric acid outflow in cortical slices and synaptosomes during morphine tolerance 172
Effect of acute and subchronic nicotine treatment on cortical efflux of [3H]‐d‐aspartate and endogenous GABA in freely moving guinea‐pigs 171
Alpha-1 adrenoreceptor-mediated increase in ACh release in brain slices during morphine tolerance 169
Resolution of a CPzI precursor, synthesis and biological evaluation of (+) and (-)-N-Boc-CPzI: A further validation of the relationship between chemical solvolytic stability and cytotoxicity 161
[3H]-MRE 3008-F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors. 157
[3H]MRE3008-F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors. 154
7-sobstituted-5-amino-2-(furyl)-pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonist: importance of modifications at the side chain on the activity and solubility. 152
Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells. 152
Generation and cycloaddition reactions of 3-substituted-2-nitro-1,3- dienes 150
New potent and selective human adenosine A3 receptor antagonists 150
Pyrazolo [4,3-E]1,2,4-triazolo[1,5-c]pyrimidine derivates a new class of potent and selective human A3 adenosine receptor antagonists. 117
Substituted 6-amino-thiouracils as new P2Y(12) receptor antagonists 115
Pharmacological and biochemical characterization of A3 adenosine receptor in Jurkat T cells. 114
Synthesis and molecular investigation of new pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivates as human A3 adenosine receptor antagonists. 108
Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]-pyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists 107
Fluorosulfonyl- and bis-(beta-chloroethyl)amino-phenylamino functionalized pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives: Irreversible antagonists at the human A(3) adenosine receptor and molecular modeling studies 107
Synthesis and molecular investigation of new pyrazolo[4,3-e]1,2,4,-triazolo[1,5-c]pyrimidine derivates as human A3 adenosine receptor antagonists. 104
Synthesis, binding and thermodynamic studies of new highly selective A2A adenosine receptor antagonists 103
Synthesis and pharmacological characterization of [3H]-MRE3008F20: the first radioligand antagonist for the human A3 adenosine receptors. 96
Synthesis and preliminary biological evaluation of [3H]-MRE 3008F20: the first high affinity radioligand antagonist for the human A3 adenosine receptors 95
Synthesis, biological properties and molecular modelling investigation of the first potent, selective and water soluble human A3 adenosine receptor antagonist. 94
Pyrazolo-triazolo-pyrimidine as human A3 adenosine receptor antagonists: influence of the substitutent at N8 pyrazole nucleus. 93
Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives: A new pharmacological tool for the characterization of the human A(3) adenosine receptor 92
Pyrazolo [4,3-E]1,2,4-trazolo[1,5-c]pyrimidine derivatives a new class of potent and selective human A3 adenosine receptor antagonists 88
Pyrazolo-triazolo-pyrimidine derivates as adenosine receptor ligands: a search for A2B adenosine receptor antagonists. 87
Second generation of A2A adenosine receptor antagonist: synthesis and biological evaluation 85
Pyrazolo[4,3-e]1,2,4-triazolo[1,5]pyrimidine derivates as irreversible antagonists at the human A3 adenosine receptor 78
An efficient synthesis of 4-oxo-2,5-hexadienoates via Δ2-isoxazoline intermediates 65
Totale 5.605
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.809
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.809
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021234 0 0 0 0 0 38 10 42 13 40 69 22
2021/2022395 9 42 19 27 20 11 11 22 17 33 46 138
2022/2023488 41 44 6 78 82 74 16 50 63 2 18 14
2023/2024198 22 26 10 5 27 26 8 12 5 3 1 53
2024/2025902 15 24 66 54 98 74 28 49 115 116 129 134
2025/20261.506 288 91 220 380 397 130 0 0 0 0 0 0
Totale 5.605